XGN
BEARISH
$2.68
Live
Exagen Inc. · NASDAQ
Target $8.67
(+223.4%)
$2.59
52W Range
$12.23
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Confidence
85%
XGN presents a high-risk profile characterized by a stable but mediocre Piotroski F-Score of 4/9 and a complete lack of positive earnings momentum. While the company maintains a strong current ratio (3.45) and healthy revenue growth (21.8%), these are offset by severe negative margins and a disastrous 6-month price collapse of 77.5%. There is a stark divergence between the 'Strong Buy' analyst consensus and the actual market behavior, including bearish insider selling by the CEO and CFO.
Key Strengths
Strong short-term liquidity with a current ratio of 3.45
Consistent double-digit revenue growth (21.8% YoY)
Attractive Price-to-Sales ratio (0.97) relative to healthcare peers
Strong gross margins (58.28%) indicating a viable core product
Significant upside gap to analyst target price ($8.67)
Key Risks
Severe profitability issues with an ROE of -147.85%
Consistent failure to meet earnings estimates (0/4 beats in last 4 quarters)
Extreme negative price momentum (down 53.1% over 1 year)
Bearish insider sentiment with sales from both CEO and CFO
Micro-cap volatility and liquidity risks
AI Fair Value Estimate
Based on comprehensive analysis
$3.15
+17.5% above current price
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare XGN against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations
Past News Coverage
Recent headlines mentioning XGN from our newsroom.
Newest → oldest
No matching news yet.